Clinical Trial: Viscoelastic Coagulation Monitoring for Early Identification of Sepsis: The VISION II Study

U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07927621) titled 'Viscoelastic Coagulation Monitoring for Early Identification of Sepsis: The VISION II Study' on Oct. 23.

Brief Summary: The VISION II study is a prospective, multicenter, observational cohort study evaluating the diagnostic performance of Viscoelastic Coagulation Monitor (VCM) parameters for the early identification of sepsis in adults presenting to the Emergency Department with suspected infection.The previous single-center, proof-of-concept VISION study (NCT07073456) showed that shorter clotting time (CT) was independently associated with sepsis and that patients with sepsis accumulated a greater number of out-of-range VCM measure...